Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of TYMP mRNA | affects expression | 21346803
|
C035208 |
2-amino-4,6-dinitrotoluene |
2-amino-4,6-dinitrotoluene affects the expression of TYMP mRNA | affects expression | 21346803
|
C035207 |
4-amino-2,6-dinitrotoluene |
4-amino-2,6-dinitrotoluene affects the expression of TYMP mRNA | affects expression | 21346803
|
C119063 |
5-chloro-6-(1-(2-iminopyrrolidinyl) methyl)uracil hydrochloride |
[5-chloro-6-(1-(2-iminopyrrolidinyl) methyl)uracil hydrochloride results in decreased activity of TYMP protein] results in decreased susceptibility to [Zidovudine co-treated with doxifluridine] | affects cotreatment|decreases activity|decreases response to substance | 16457948
|
C119063 |
5-chloro-6-(1-(2-iminopyrrolidinyl) methyl)uracil hydrochloride |
[5-chloro-6-(1-(2-iminopyrrolidinyl) methyl)uracil hydrochloride results in decreased activity of TYMP protein] which results in decreased susceptibility to doxifluridine | decreases activity|decreases response to substance | 16457948
|
C119063 |
5-chloro-6-(1-(2-iminopyrrolidinyl) methyl)uracil hydrochloride |
5-chloro-6-(1-(2-iminopyrrolidinyl) methyl)uracil hydrochloride results in decreased activity of TYMP protein | decreases activity | 16457948
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of TYMP mRNA | affects expression | 17562736
|
C095512 |
alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide |
alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [IFNA1 protein results in increased expression of TYMP mRNA] | decreases reaction|increases expression | 15937643
|
C095512 |
alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide |
alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [IFNB1 protein results in increased expression of TYMP mRNA] | decreases reaction|increases expression | 15937643
|
C095512 |
alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide |
alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [IFNG protein results in increased expression of TYMP mRNA] | decreases reaction|increases expression | 15937643
|
C006780 |
bisphenol A |
bisphenol A results in decreased expression of TYMP mRNA | decreases expression | 20678512
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in increased expression of TYMP mRNA | increases expression | 14729362
|
D003520 |
Cyclophosphamide |
[Doxorubicin co-treated with Cyclophosphamide] results in increased expression of TYMP protein | affects cotreatment|increases expression | 15150550
|
D003520 |
Cyclophosphamide |
[Epirubicin co-treated with Cyclophosphamide] results in increased expression of TYMP protein | affects cotreatment|increases expression | 15150550
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of TYMP mRNA | increases expression | 20106945
|
D018119 |
Stavudine |
Stavudine results in increased expression of TYMP protein | increases expression | 16457948
|
D003609 |
Dactinomycin |
Dactinomycin inhibits the reaction [IFNA1 protein results in increased expression of TYMP mRNA] | decreases reaction|increases expression | 15937643
|
D003609 |
Dactinomycin |
Dactinomycin inhibits the reaction [IFNB1 protein results in increased expression of TYMP mRNA] | decreases reaction|increases expression | 15937643
|
D003609 |
Dactinomycin |
Dactinomycin inhibits the reaction [IFNG protein results in increased expression of TYMP mRNA] | decreases reaction|increases expression | 15937643
|
D016047 |
Zalcitabine |
Zalcitabine results in increased expression of TYMP protein | increases expression | 16457948
|
D002945 |
Cisplatin |
[Cisplatin co-treated with Fluorouracil] results in decreased expression of TYMP mRNA | affects cotreatment|decreases expression | 17638652
|
D002945 |
Cisplatin |
Cisplatin results in decreased expression of TYMP mRNA | decreases expression | 16568373
|
D002945 |
Cisplatin |
[TYMP protein co-treated with DPYD protein] affects the susceptibility to Cisplatin | affects cotreatment|affects response to substance | 18728667
|
C067311 |
docetaxel |
[FEC protocol co-treated with docetaxel] results in increased expression of TYMP protein | affects cotreatment|increases expression | 15150550
|
C025034 |
doxifluridine |
[5-chloro-6-(1-(2-iminopyrrolidinyl) methyl)uracil hydrochloride results in decreased activity of TYMP protein] results in decreased susceptibility to [Zidovudine co-treated with doxifluridine] | affects cotreatment|decreases activity|decreases response to substance | 16457948
|
C025034 |
doxifluridine |
[5-chloro-6-(1-(2-iminopyrrolidinyl) methyl)uracil hydrochloride results in decreased activity of TYMP protein] which results in decreased susceptibility to doxifluridine | decreases activity|decreases response to substance | 16457948
|
C025034 |
doxifluridine |
doxifluridine affects the expression of TYMP mRNA | affects expression | 18630517
|
C025034 |
doxifluridine |
doxifluridine promotes the reaction [TNF protein results in increased expression of TYMP mRNA] | increases expression|increases reaction | 17988526
|
C025034 |
doxifluridine |
[IFNG protein results in increased expression of TYMP protein] which results in increased susceptibility to doxifluridine | increases expression|increases response to substance | 15301717
|
C025034 |
doxifluridine |
[Paclitaxel co-treated with doxifluridine] affects the expression of TYMP mRNA | affects cotreatment|affects expression | 18630517
|
C025034 |
doxifluridine |
[TYMP protein results in increased expression of IFNA1 mRNA] which results in increased susceptibility to doxifluridine | increases expression|increases response to substance | 17988526
|
C025034 |
doxifluridine |
TYMP protein results in increased susceptibility to doxifluridine | increases response to substance | 15864645
|
C025034 |
doxifluridine |
[Zidovudine results in increased activity of TYMP protein] which results in increased susceptibility to doxifluridine | increases activity|increases response to substance | 16457948
|
D004317 |
Doxorubicin |
[Doxorubicin co-treated with Cyclophosphamide] results in increased expression of TYMP protein | affects cotreatment|increases expression | 15150550
|
D004391 |
Dust |
Dust results in decreased expression of TYMP mRNA | decreases expression | 17805423
|
D015251 |
Epirubicin |
[Epirubicin co-treated with Cyclophosphamide] results in increased expression of TYMP protein | affects cotreatment|increases expression | 15150550
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of TYMP mRNA | decreases expression | 15953391
|
C052498 |
FEC protocol |
[FEC protocol co-treated with docetaxel] results in increased expression of TYMP protein | affects cotreatment|increases expression | 15150550
|
D005472 |
Fluorouracil |
[Cisplatin co-treated with Fluorouracil] results in decreased expression of TYMP mRNA | affects cotreatment|decreases expression | 17638652
|
D005472 |
Fluorouracil |
Fluorouracil results in decreased expression of TYMP mRNA | decreases expression | 16568373
|
D005472 |
Fluorouracil |
[IFNG protein results in increased expression of TYMP protein] which results in increased susceptibility to Fluorouracil | increases expression|increases response to substance | 15301717
|
D005472 |
Fluorouracil |
TYMP mRNA affects the susceptibility to [irinotecan co-treated with Fluorouracil co-treated with Leucovorin] | affects cotreatment|affects response to substance | 17454858
|
D005472 |
Fluorouracil |
TYMP protein affects the susceptibility to Fluorouracil | affects response to substance | 15041737 15538739 16160472 15655543
|
D005472 |
Fluorouracil |
TYMP mRNA results in decreased susceptibility to Fluorouracil | decreases response to substance | 16525674
|
D002955 |
Leucovorin |
TYMP mRNA affects the susceptibility to [irinotecan co-treated with Fluorouracil co-treated with Leucovorin] | affects cotreatment|affects response to substance | 17454858
|
C056933 |
fumonisin B1 |
fumonisin B1 results in decreased expression of TYMP mRNA | decreases expression | 16221962
|
C056507 |
gemcitabine |
TYMP protein affects the susceptibility to gemcitabine | affects response to substance | 18728667
|
C056507 |
gemcitabine |
TYMP protein affects the susceptibility to [gemcitabine co-treated with Mitomycin] | affects cotreatment|affects response to substance | 18728667
|
C056507 |
gemcitabine |
[TYMP protein co-treated with DPYD protein] affects the susceptibility to gemcitabine | affects cotreatment|affects response to substance | 18728667
|
D006072 |
Gossypol |
Gossypol inhibits the reaction [zoledronic acid results in increased expression of TYMP mRNA] | decreases reaction|increases expression | 19825521
|
C029424 |
hydrazine |
hydrazine results in decreased expression of TYMP mRNA | decreases expression | 15282401
|
C051890 |
irinotecan |
TYMP mRNA affects the susceptibility to [irinotecan co-treated with Fluorouracil co-treated with Leucovorin] | affects cotreatment|affects response to substance | 17454858
|
D016685 |
Mitomycin |
Mitomycin results in decreased expression of TYMP mRNA | decreases expression | 16568373
|
D016685 |
Mitomycin |
TYMP protein affects the susceptibility to [gemcitabine co-treated with Mitomycin] | affects cotreatment|affects response to substance | 18728667
|
C030110 |
oxaliplatin |
TYMP protein affects the susceptibility to oxaliplatin | affects response to substance | 18728667
|
C030110 |
oxaliplatin |
[TYMP protein co-treated with DPYD protein] affects the susceptibility to oxaliplatin | affects cotreatment|affects response to substance | 18728667
|
D010126 |
Ozone |
Ozone results in decreased expression of TYMP mRNA | decreases expression | 12763052
|
D017239 |
Paclitaxel |
[Paclitaxel co-treated with doxifluridine] affects the expression of TYMP mRNA | affects cotreatment|affects expression | 18630517
|
D017239 |
Paclitaxel |
Paclitaxel results in increased expression of TYMP mRNA | increases expression | 18630517
|
C085586 |
pemetrexed |
TYMP protein results in increased susceptibility to pemetrexed | increases response to substance | 17575230
|
D010634 |
Phenobarbital |
NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of TYMP mRNA] | affects reaction|decreases expression | 19482888
|
D010634 |
Phenobarbital |
Phenobarbital results in decreased expression of TYMP mRNA | decreases expression | 19482888
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of TYMP mRNA | increases expression | 17426115 18445702
|
C079198 |
S 1 (combination) |
S 1 (combination) results in increased expression of TYMP mRNA | increases expression | 18506536
|
D012643 |
Selenium |
Selenium results in increased expression of TYMP mRNA | increases expression | 19244175
|
D014810 |
Vitamin E |
Vitamin E results in increased expression of TYMP mRNA | increases expression | 19244175
|
D015215 |
Zidovudine |
[5-chloro-6-(1-(2-iminopyrrolidinyl) methyl)uracil hydrochloride results in decreased activity of TYMP protein] results in decreased susceptibility to [Zidovudine co-treated with doxifluridine] | affects cotreatment|decreases activity|decreases response to substance | 16457948
|
D015215 |
Zidovudine |
Zidovudine results in increased activity of TYMP protein | increases activity | 16457948
|
D015215 |
Zidovudine |
[Zidovudine results in increased activity of TYMP protein] which results in increased susceptibility to doxifluridine | increases activity|increases response to substance | 16457948
|
D015215 |
Zidovudine |
Zidovudine results in increased expression of TYMP mRNA | increases expression | 16457948
|
D015215 |
Zidovudine |
Zidovudine results in increased expression of TYMP protein | increases expression | 16457948
|
C088658 |
zoledronic acid |
Gossypol inhibits the reaction [zoledronic acid results in increased expression of TYMP mRNA] | decreases reaction|increases expression | 19825521
|
C088658 |
zoledronic acid |
zoledronic acid results in increased expression of TYMP mRNA | increases expression | 19825521
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
2-amino-4,6-dinitrotoluene |
12.13 | 7525203 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
4-amino-2,6-dinitrotoluene |
12.13 | 7525203 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
12.13 | 6195326 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.52 | 17505938 |
MESH:D000163 |
Acquired Immunodeficiency Syndrome |
|
Zidovudine |
4.42 | 9612607 |
MESH:D058186 |
Acute Kidney Injury |
|
Cisplatin |
7.87 | 15814532 12690470 17670903 |
MESH:D058186 |
Acute Kidney Injury |
|
zoledronic acid |
7.87 | 19715164 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
2.73 | 18653653 |
MESH:D000210 |
Acute-Phase Reaction |
|
zoledronic acid |
5.06 | 20200999 |
MESH:D000230 |
Adenocarcinoma |
|
Cisplatin |
9.20 | 11798837 17638652 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
9.20 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
9.20 | 14692618 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
9.20 | 17638652 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
8.73 | 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
8.73 | 16434500 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.15 | 21441931 |
MESH:D000544 |
Alzheimer Disease |
|
Ozone |
2.34 | 15513908 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
3.35 | 15504547 17963324 16511603 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.42 | 10982225 |
MESH:D001161 |
Arteriosclerosis |
|
Cyclophosphamide |
8.81 | 15014928 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
8.81 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.40 | 15885639 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
2.45 | 15570426 |
MESH:D001249 |
Asthma |
|
Ozone |
2.50 | 17854713 16373670 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.47 | 18445737 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
2.77 | 19483382 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Cisplatin |
17.95 | 14601052 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Dactinomycin |
17.95 | 14601052 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
17.95 | 14601052 |
MESH:D001859 |
Bone Neoplasms |
|
Paclitaxel |
9.55 | 15867366 |
MESH:D001859 |
Bone Neoplasms |
|
zoledronic acid |
9.55 | 17312309 16121404 16778634 15867366 11697798 19442620 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
8.55 | 11985600 |
MESH:D001862 |
Bone Resorption |
|
zoledronic acid |
8.55 | 8053405 16769263 18496637 18404659 11869084 15845617 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.45 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
9.01 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Cisplatin |
9.01 | 19526202 18382427 |
MESH:D001943 |
Breast Neoplasms |
|
Cyclophosphamide |
9.01 | 11325840 17388661 17020986 15136595 18323546 12006526 15093573 16978400 18234424 |
MESH:D001943 |
Breast Neoplasms |
|
docetaxel |
9.01 | 15567936 17369602 15692762 18628466 16264153 19526202 16495393 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
9.01 | 18628466 15692762 17983394 16595493 18234424 15567936 16096432 15136595 16115903 18695136 11325840 17426702 17369602 15634643 15668708 16322301 18382427 16826403 15939500 16935488 19526202 15994142 15993339 16264153 |
MESH:D001943 |
Breast Neoplasms |
|
Epirubicin |
9.01 | 15093573 17388661 12006526 18511948 16642371 |
MESH:D001943 |
Breast Neoplasms |
|
FEC protocol |
9.01 | 16682728 15970926 17145825 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
9.01 | 18357371 16557594 18608205 16595493 16110121 19217205 15136595 |
MESH:D001943 |
Breast Neoplasms |
|
gemcitabine |
9.01 | 18382427 17039268 |
MESH:D001943 |
Breast Neoplasms |
|
Paclitaxel |
9.01 | 18223236 11325840 18323546 16273361 18234424 16244791 15136595 16115903 |
MESH:D001943 |
Breast Neoplasms |
|
pemetrexed |
9.01 | 17575230 17465208 |
MESH:D001943 |
Breast Neoplasms |
|
zoledronic acid |
9.01 | 16096432 18695136 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
3.35 | 17626835 15516495 16777450 18315731 14754758 19059883 18417511 |
MESH:D002100 |
Cachexia |
|
Ozone |
4.32 | 16183385 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Vitamin E |
3.52 | 16050911 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
10.93 | 16051944 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
10.93 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
3.24 | 17121937 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
15.49 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
15.49 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cisplatin |
15.49 | 17982673 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cyclophosphamide |
15.49 | 19701751 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
15.49 | 16023760 16234567 18059187 17876044 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
15.49 | 17971768 16332177 16799960 17045692 17088986 18930000 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Paclitaxel |
15.49 | 16313753 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
15.49 | 1701930 6705139 17173139 20007298 20935162 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.57 | 17123778 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
Cyclophosphamide |
4.47 | 16152834 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Cisplatin |
15.19 | 12023789 16685392 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
docetaxel |
15.19 | 11894018 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
pemetrexed |
15.19 | 12023789 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
S 1 (combination) |
15.19 | 18347146 18212800 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
zoledronic acid |
15.19 | 19233551 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Cyclophosphamide |
13.73 | 16201981 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
13.73 | 1485588 16201981 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
13.73 | 18695887 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
zoledronic acid |
13.73 | 18507039 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Cisplatin |
9.77 | 18337622 6189445 17066447 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
9.77 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
9.77 | 17066447 16280240 18986760 16757204 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
S 1 (combination) |
9.77 | 15984520 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
7.48 | 17351982 15811867 16651473 17007740 16731534 17308081 16952015 17519947 15505089 17974986 18627295 17382496 16278810 16612575 16109756 15792986 17924179 17131338 17928571 16455267 15476868 17329180 16364871 16269455 16242529 |
MESH:D009202 |
Cardiomyopathies |
|
Zalcitabine |
7.48 | 10591146 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.79 | 16243910 17334414 |
MESH:D002386 |
Cataract |
|
4-amino-2,6-dinitrotoluene |
6.58 | 14694615 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
6.58 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
2.24 | 12371664 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
3.84 | 4080065 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
11.54 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
11.54 | 15861022 17681005 11677210 16919318 17333356 16105132 17110522 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
11.54 | 19176532 |
MESH:D003092 |
Colitis |
|
Selenium |
3.37 | 17936198 |
MESH:D003110 |
Colonic Neoplasms |
marker/mechanism |
|
| 18652704 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
5.49 | 17169374 17172411 17016597 16340194 17018589 15001691 16510598 17287894 18772588 17725105 |
MESH:D003110 |
Colonic Neoplasms |
|
irinotecan |
5.49 | 17725105 17287894 |
MESH:D003110 |
Colonic Neoplasms |
|
oxaliplatin |
5.49 | 16510598 16024531 16004971 |
MESH:D015179 |
Colorectal Neoplasms |
marker/mechanism |
|
| 15706408 17047489 |
MESH:D015179 |
Colorectal Neoplasms |
|
Cisplatin |
9.73 | 15273666 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
9.73 | 18802399 18259882 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
9.73 | 17695437 17255274 18448328 18288408 16524972 17094418 16391804 17454858 15148649 18509181 16282729 16303861 18383874 20501625 17594712 17401013 18949393 18802399 15289873 16331619 17016601 14970324 |
MESH:D015179 |
Colorectal Neoplasms |
|
irinotecan |
9.73 | 16391804 16303861 17159606 15273666 17454858 18259882 18509181 |
MESH:D015179 |
Colorectal Neoplasms |
|
Leucovorin |
9.73 | 17454858 17594712 17401013 17255274 16303861 20501625 |
MESH:D015179 |
Colorectal Neoplasms |
|
oxaliplatin |
9.73 | 18509181 18448328 17401013 17695437 17594712 17255274 |
MESH:D015179 |
Colorectal Neoplasms |
|
Paclitaxel |
9.73 | 18802399 |
MESH:D000013 |
Congenital Abnormalities |
|
2-amino-4,6-dinitrotoluene |
8.80 | 15095906 |
MESH:D000013 |
Congenital Abnormalities |
|
4-amino-2,6-dinitrotoluene |
8.80 | 15095906 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Leucovorin |
3.18 | 16925845 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Vitamin E |
3.18 | 19769572 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
3.61 | 18551238 |
MESH:D003556 |
Cystitis |
|
Cyclophosphamide |
4.56 | 18295254 16413132 11948286 12388444 18433785 16614059 10700343 18372110 18483878 10498854 17979934 15276878 16989017 18093676 15643279 12913760 17010015 16651033 18710439 12161096 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
4.37 | 16733453 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.22 | 18249437 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Cyclophosphamide |
3.73 | 11751995 15331540 10990075 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Cyclophosphamide |
3.08 | 18772604 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
16.51 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2-amino-4,6-dinitrotoluene |
16.51 | 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4-amino-2,6-dinitrotoluene |
16.51 | 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
16.51 | 12594235 10915739 10774834 11287661 11834606 18713872 16109766 19739265 15619225 12705907 19085960 16781746 12958197 19416960 12540782 18071297 11739529 17906064 17562736 12153990 16081117 14725611 12392966 11461765 16485898 10663392 11743745 14550746 16177239 11421492 11529661 15968718 14986274 2444490 19420014 19370779 16393943 19164858 19923254 16227642 17522070 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
16.51 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
fumonisin B1 |
16.51 | 16221962 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
16.51 | 15131321 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.67 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Cisplatin |
22.49 | 12231392 15033597 19839026 12649298 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
22.49 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Stavudine |
22.49 | 15040536 |
MESH:D004362 |
Drug Toxicity |
|
Zalcitabine |
22.49 | 7515130 |
MESH:D004362 |
Drug Toxicity |
|
Zidovudine |
22.49 | 15040536 |
MESH:D004421 |
Dystonia |
|
Phenobarbital |
3.62 | 1851702 |
MESH:C538011 |
Eales disease |
|
Vitamin E |
4.28 | 9068938 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.13 | 12083418 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
2.79 | 12538720 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
3.18 | 17359293 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
4.73 | 18037988 |
MESH:D004802 |
Eosinophilia |
|
Cyclophosphamide |
3.81 | 11006010 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
3.70 | 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
3.45 | 11558140 3922381 |
MESH:D004827 |
Epilepsy |
|
Phenobarbital |
2.67 | 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
3.19 | 6401628 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
3.84 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
3.60 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
Cisplatin |
9.51 | 16785472 16481741 17638652 15173087 15464296 |
MESH:D004938 |
Esophageal Neoplasms |
|
docetaxel |
9.51 | 16337965 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
9.51 | 16481741 16785472 15173087 16337965 17638652 |
MESH:D004938 |
Esophageal Neoplasms |
|
Paclitaxel |
9.51 | 16481741 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
25.89 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
25.89 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
25.89 | 19236843 20131406 |
MESH:D005234 |
Fatty Liver |
|
Stavudine |
25.89 | 18299183 |
MESH:D005234 |
Fatty Liver |
|
Zalcitabine |
25.89 | 18299183 |
MESH:D005234 |
Fatty Liver |
|
Zidovudine |
25.89 | 18299183 |
MESH:D005264 |
Femoral Fractures |
|
zoledronic acid |
5.41 | 16234978 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.17 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
2.74 | 12168785 12639820 |
MESH:D005706 |
Gallbladder Neoplasms |
|
S 1 (combination) |
5.36 | 19093184 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.25 | 16983495 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
3.80 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
3.08 | 17150277 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
2.69 | 16145905 |
MESH:D018316 |
Gliosarcoma |
|
Cyclophosphamide |
5.09 | 11389073 |
MESH:D006086 |
Graft vs Host Disease |
|
Cyclophosphamide |
4.63 | 15172196 16376943 11014644 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Cisplatin |
16.20 | 15102660 15464296 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
16.20 | 15692506 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
16.20 | 15102660 15162350 18337622 |
MESH:D006258 |
Head and Neck Neoplasms |
|
S 1 (combination) |
16.20 | 15984520 18607998 |
MESH:D034381 |
Hearing Loss |
|
Cisplatin |
3.94 | 19898482 |
MESH:D006319 |
Hearing Loss, Sensorineural |
|
Cisplatin |
4.08 | 15464296 |
MESH:D006330 |
Heart Defects, Congenital |
|
Vitamin E |
2.76 | 16080930 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.19 | 18006777 14766674 17875725 12587719 16495754 16244371 16244372 18674790 16144979 17888722 16330681 16879835 16707910 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
10.27 | 17481944 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
10.27 | 20558911 |
MESH:D006333 |
Heart Failure |
|
Selenium |
10.27 | 17162251 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.53 | 15692506 |
MESH:D006402 |
Hematologic Diseases |
|
Zidovudine |
4.33 | 12579204 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.00 | 15720958 |
MESH:D006467 |
Hemophilia A |
|
Cyclophosphamide |
4.88 | 11918545 |
MESH:D006504 |
Hepatic Veno-Occlusive Disease |
|
Cyclophosphamide |
5.11 | 14986274 |
MESH:D006529 |
Hepatomegaly |
|
fumonisin B1 |
12.21 | 16221962 |
MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
12.21 | 16109766 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
12.21 | 18467677 16221962 19772884 19176532 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Vitamin E |
2.55 | 16863852 16490937 |
MESH:D015658 |
HIV Infections |
|
Stavudine |
9.89 | 11141242 |
MESH:D015658 |
HIV Infections |
|
Zalcitabine |
9.89 | 17457083 |
MESH:D015658 |
HIV Infections |
|
Zidovudine |
9.89 | 17358032 11363243 11141242 11698656 20032539 |
MESH:D006689 |
Hodgkin Disease |
|
Cisplatin |
14.75 | 16170182 16200630 |
MESH:D006689 |
Hodgkin Disease |
|
Cyclophosphamide |
14.75 | 16135485 17606976 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
14.75 | 18501091 17606976 15147373 |
MESH:D006689 |
Hodgkin Disease |
|
Epirubicin |
14.75 | 18180244 |
MESH:D019584 |
Hot Flashes |
|
Vitamin E |
3.55 | 14716179 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
11.39 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
oxaliplatin |
11.39 | 17418472 |
MESH:D006930 |
Hyperalgesia |
|
zoledronic acid |
11.39 | 16769263 |
MESH:D006934 |
Hypercalcemia |
|
zoledronic acid |
4.67 | 18089816 19622757 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
2.82 | 20558911 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
1.94 | 10903974 |
MESH:D006996 |
Hypocalcemia |
|
zoledronic acid |
5.77 | 12669777 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.40 | 16945680 16569931 |
MESH:D007154 |
Immune System Diseases |
|
Cyclophosphamide |
4.90 | 16076520 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.08 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Cyclophosphamide |
9.90 | 16517039 7193160 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
9.90 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
Gossypol |
9.90 | 11202417 9639145 |
MESH:D007251 |
Influenza, Human |
|
Selenium |
9.54 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
Vitamin E |
9.54 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
6.39 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
6.39 | 16306350 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.01 | 15604871 |
MESH:D007673 |
Kidney Cortex Necrosis |
|
Cisplatin |
4.71 | 15464296 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
16.41 | 12587719 15629191 |
MESH:D007674 |
Kidney Diseases |
|
Cisplatin |
16.41 | 15190930 12231392 12649298 19839026 18289764 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
16.41 | 18776723 10903974 8314463 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
16.41 | 16775033 15699352 15369732 |
MESH:D007674 |
Kidney Diseases |
|
Vitamin E |
16.41 | 12488133 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
8.74 | 16707910 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
8.74 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
15.01 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
15.01 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
15.01 | 16985049 |
MESH:D007680 |
Kidney Neoplasms |
|
Zidovudine |
15.01 | 12579204 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Cisplatin |
4.37 | 11231351 |
MESH:D007938 |
Leukemia |
|
Cyclophosphamide |
3.28 | 10602166 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
4.73 | 16085563 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Cyclophosphamide |
3.31 | 17008537 18587576 18172266 17802794 17296974 17658394 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
Zidovudine |
8.95 | 20370541 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
zoledronic acid |
8.95 | 18089816 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Cyclophosphamide |
3.78 | 10373061 |
MESH:D007970 |
Leukopenia |
|
Cyclophosphamide |
4.55 | 11830472 10052129 |
MESH:D008080 |
Liposarcoma |
|
Paclitaxel |
4.43 | 17353645 |
MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
2.66 | 21047994 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
3.21 | 16439617 16595196 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
3.21 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Vitamin E |
3.21 | 16169303 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
3.53 | 19014921 12969438 16610002 16611625 19784758 11587558 19460945 12587719 |
MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
3.53 | 19363144 |
MESH:D017093 |
Liver Failure |
|
Stavudine |
5.45 | 18299183 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
2.87 | 16871587 17185352 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
9.33 | 16603448 15113037 18383874 17045692 |
MESH:D008113 |
Liver Neoplasms |
|
Mitomycin |
9.33 | 15113037 |
MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
9.33 | 21047994 8742319 15975961 19482888 19812893 19073162 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
9.33 | 16377806 20007298 15890375 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
5.25 | 16842330 17085340 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
5.25 | 1399818 2563599 6150874 17172636 18308698 |
MESH:D008171 |
Lung Diseases |
|
Ozone |
6.57 | 19066396 8266340 |
MESH:D008171 |
Lung Diseases |
|
Vitamin E |
6.57 | 16863852 |
MESH:D055370 |
Lung Injury |
|
Ozone |
3.44 | 20417186 |
MESH:D008175 |
Lung Neoplasms |
|
Cisplatin |
7.76 | 6189445 17225452 11798837 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
7.76 | 17418594 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
7.76 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
Ozone |
7.76 | 8597069 7614698 |
MESH:D008175 |
Lung Neoplasms |
|
Vitamin E |
7.76 | 11062179 |
MESH:D008175 |
Lung Neoplasms |
|
Zidovudine |
7.76 | 18800350 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.37 | 15086387 |
MESH:D008223 |
Lymphoma |
|
Cyclophosphamide |
11.11 | 12854902 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
11.11 | 16098063 |
MESH:D008223 |
Lymphoma |
|
Zalcitabine |
11.11 | 11980663 9488045 18798262 8764131 9205081 8840982 17941976 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Cyclophosphamide |
4.21 | 16675587 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Cyclophosphamide |
12.70 | 11911406 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
12.70 | 17654614 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Paclitaxel |
12.70 | 14749477 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.16 | 15621674 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
8.58 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
8.58 | 15318939 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
zoledronic acid |
8.58 | 17312309 |
MESH:D008545 |
Melanoma |
|
Cisplatin |
8.92 | 16809738 11135225 18176117 12393984 16432458 16248763 15577323 17761969 18505091 17023156 12883367 18332650 12374674 |
MESH:D008545 |
Melanoma |
|
docetaxel |
8.92 | 12417787 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
8.92 | 16827129 |
MESH:D008545 |
Melanoma |
|
Epirubicin |
8.92 | 16642371 |
MESH:D008545 |
Melanoma |
|
Paclitaxel |
8.92 | 12025231 12040289 16342250 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Cisplatin |
4.36 | 15990972 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
9.47 | 19513568 |
MESH:D008546 |
Melanoma, Experimental |
|
Cyclophosphamide |
9.47 | 16388313 |
MESH:D008654 |
Mesothelioma |
|
Cisplatin |
13.11 | 17638057 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
13.11 | 17638057 |
MESH:D008654 |
Mesothelioma |
|
Selenium |
13.11 | 15107826 |
MESH:D008654 |
Mesothelioma |
|
zoledronic acid |
13.11 | 16675582 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.36 | 16801185 |
MESH:D008679 |
Metaplasia |
|
Ozone |
4.68 | 10496685 |
MESH:D048629 |
Micronuclei, Chromosome-Defective |
|
Zidovudine |
5.41 | 17358032 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.12 | 15792986 |
MESH:C537477 |
Mitochondrial neurogastrointestinal encephalopathy syndrome |
marker/mechanism |
|
| |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
3.31 | 16757204 18986760 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
11.02 | 17415656 |
MESH:D052016 |
Mucositis |
|
irinotecan |
11.02 | 17159606 |
MESH:D009101 |
Multiple Myeloma |
|
Paclitaxel |
6.86 | 14749477 |
MESH:D009101 |
Multiple Myeloma |
|
zoledronic acid |
6.86 | 19621390 18089719 16996129 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.10 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
5.09 | 19429709 15857846 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
5.09 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.63 | 16411023 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
4.06 | 17484760 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
3.44 | 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
12.21 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
irinotecan |
12.21 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
Paclitaxel |
12.21 | 15867366 |
MESH:D009362 |
Neoplasm Metastasis |
|
zoledronic acid |
12.21 | 19139120 15867366 17312309 |
MESH:D009369 |
Neoplasms |
|
Cisplatin |
10.12 | 16773208 |
MESH:D009369 |
Neoplasms |
|
Cyclophosphamide |
10.12 | 18854779 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
10.12 | 16928823 18600527 18239605 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
10.12 | 17405874 |
MESH:D009374 |
Neoplasms, Experimental |
|
Zalcitabine |
4.70 | 9205081 8764131 9488045 |
MESH:D009395 |
Nephritis, Interstitial |
|
Cisplatin |
4.07 | 15464296 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.36 | 16636307 16899518 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.01 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
8.13 | 19348381 18481113 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
8.13 | 15640375 16889571 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
3.58 | 11399458 16427766 |
MESH:D009437 |
Neuralgia |
|
Zalcitabine |
5.90 | 17292584 |
MESH:D009447 |
Neuroblastoma |
|
Cisplatin |
14.45 | 8761367 |
MESH:D009447 |
Neuroblastoma |
|
Cyclophosphamide |
14.45 | 16115947 8761367 15176712 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
14.45 | 15555623 |
MESH:D009447 |
Neuroblastoma |
|
irinotecan |
14.45 | 8761367 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
2.53 | 18514411 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cisplatin |
16.68 | 8761367 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cyclophosphamide |
16.68 | 8761367 12837982 |
MESH:D017599 |
Neuroectodermal Tumors |
|
irinotecan |
16.68 | 8761367 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.15 | 16436463 |
MESH:D009503 |
Neutropenia |
|
Cyclophosphamide |
8.91 | 8291058 |
MESH:D009503 |
Neutropenia |
|
pemetrexed |
8.91 | 16322990 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.70 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
7.93 | 12819281 16049721 |
MESH:D009784 |
Occupational Diseases |
|
4-amino-2,6-dinitrotoluene |
7.93 | 14694615 |
MESH:D009845 |
Oligospermia |
|
Cyclophosphamide |
4.29 | 16517039 |
MESH:D010014 |
Osteolysis |
|
Paclitaxel |
10.89 | 15867366 |
MESH:D010014 |
Osteolysis |
|
zoledronic acid |
10.89 | 15867366 |
MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
3.94 | 17016548 |
MESH:D010024 |
Osteoporosis |
|
zoledronic acid |
3.77 | 17882678 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
3.78 | 15930896 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.57 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
Cisplatin |
4.80 | 17225452 6897625 15464296 19769630 |
MESH:D010051 |
Ovarian Neoplasms |
|
Paclitaxel |
4.80 | 11161223 |
MESH:D010146 |
Pain |
|
Acetaminophen |
9.49 | 16870215 |
MESH:D010146 |
Pain |
|
Cyclophosphamide |
9.49 | 18093676 12161096 |
MESH:D010146 |
Pain |
|
zoledronic acid |
9.49 | 16475674 |
MESH:D010190 |
Pancreatic Neoplasms |
marker/mechanism |
|
| 17443278 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cisplatin |
18.37 | 19003803 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cyclophosphamide |
18.37 | 11332152 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
18.37 | 16929163 15113037 19003803 16500647 |
MESH:D010190 |
Pancreatic Neoplasms |
|
gemcitabine |
18.37 | 18992248 18383843 16929163 17440100 11504793 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Mitomycin |
18.37 | 15113037 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
18.37 | 16965848 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.30 | 11578682 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Cisplatin |
9.15 | 15464296 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Zalcitabine |
9.15 | 18606552 |
MESH:D010538 |
Peritonitis |
|
Ozone |
3.72 | 16369182 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
4.73 | 17983394 |
MESH:D010954 |
Plasmacytoma |
|
Selenium |
4.46 | 15087411 |
MESH:D010997 |
Pleural Neoplasms |
|
Cisplatin |
12.51 | 17638057 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
12.51 | 17638057 |
MESH:D011014 |
Pneumonia |
|
Ozone |
3.98 | 18381685 18929643 18007984 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
7.80 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
7.80 | 2563599 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Cyclophosphamide |
3.56 | 21297632 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
3.54 | 10548101 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
3.83 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
2.34 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cyclophosphamide |
2.34 | 17136230 |
MESH:D011471 |
Prostatic Neoplasms |
|
docetaxel |
2.34 | 18824434 19103299 16644109 16520278 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
2.34 | 15749863 15897917 16729912 16888761 18437689 16868541 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
2.34 | 19082440 18626508 |
MESH:D011471 |
Prostatic Neoplasms |
|
Paclitaxel |
2.34 | 17136230 16356831 16729912 17172428 |
MESH:D011471 |
Prostatic Neoplasms |
|
Vitamin E |
2.34 | 15084515 |
MESH:D011471 |
Prostatic Neoplasms |
|
zoledronic acid |
2.34 | 19103299 12438248 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
2.90 | 15861022 16919318 |
MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
4.07 | 12752131 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.07 | 16882103 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.37 | 10548101 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Cyclophosphamide |
3.11 | 16636934 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
3.66 | 16160472 15538739 18286688 18722050 |
MESH:D051437 |
Renal Insufficiency |
|
Cisplatin |
9.02 | 15464296 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
9.02 | 17922066 |
MESH:D015427 |
Reperfusion Injury |
|
Leucovorin |
6.34 | 17295595 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
6.34 | 19058328 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.63 | 18313854 17203757 17710206 15625365 15675481 16767912 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Cisplatin |
21.42 | 14601052 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Dactinomycin |
21.42 | 14601052 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
21.42 | 14601052 16326096 |
MESH:D012512 |
Sarcoma, Ewing's |
|
zoledronic acid |
21.42 | 16121404 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.37 | 17846226 |
MESH:D012595 |
Scleroderma, Systemic |
|
Cyclophosphamide |
4.44 | 16636934 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
4.98 | 18551238 |
MESH:D012640 |
Seizures |
|
Phenobarbital |
4.98 | 16876388 4039156 11442880 3137016 |
MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
4.40 | 6407741 |
MESH:D012871 |
Skin Diseases |
|
Vitamin E |
2.33 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
5.23 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
5.23 | 8532709 |
MESH:D055752 |
Small Cell Lung Carcinoma |
|
Cisplatin |
4.92 | 15464296 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.16 | 15625365 17203757 16767912 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
3.52 | 16709447 |
OMIM:102530 |
SPERMATOGENIC FAILURE 6 |
|
Cyclophosphamide |
5.09 | 16517039 |
MESH:D013274 |
Stomach Neoplasms |
marker/mechanism |
|
| 18652704 |
MESH:D013274 |
Stomach Neoplasms |
|
Cisplatin |
11.70 | 17522103 18396642 15958060 |
MESH:D013274 |
Stomach Neoplasms |
|
docetaxel |
11.70 | 16557585 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
11.70 | 19015929 19084572 18567086 15786421 16951190 17522103 17172411 17498489 18396642 16424979 |
MESH:D013274 |
Stomach Neoplasms |
|
irinotecan |
11.70 | 15723263 |
MESH:D013274 |
Stomach Neoplasms |
|
Paclitaxel |
11.70 | 18506536 18396642 |
MESH:D013274 |
Stomach Neoplasms |
|
pemetrexed |
11.70 | 15958060 |
MESH:D013274 |
Stomach Neoplasms |
|
S 1 (combination) |
11.70 | 18553229 16557585 18506536 |
MESH:D013274 |
Stomach Neoplasms |
|
Zidovudine |
11.70 | 17696246 |
MESH:D020521 |
Stroke |
|
Vitamin E |
3.19 | 16517955 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.57 | 16684133 16045194 |
MESH:D015173 |
Supratentorial Neoplasms |
|
Cyclophosphamide |
4.64 | 12837982 |
MESH:D024801 |
Tauopathies |
|
Paclitaxel |
4.39 | 16930453 |
MESH:D013736 |
Testicular Neoplasms |
|
Cisplatin |
4.24 | 15464296 17225452 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.23 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
2.80 | 15669648 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
6.27 | 16010429 17909728 |
MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
6.27 | 1399818 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
3.63 | 16280240 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
10.53 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cisplatin |
10.53 | 12973940 17225452 15464296 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cyclophosphamide |
10.53 | 14692829 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
10.53 | 17653716 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
3.90 | 10091137 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.60 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Cisplatin |
8.44 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
8.44 | 16803524 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
4.58 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
2.90 | 14692618 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.56 | 1336536 |
MESH:D014625 |
Vaginal Neoplasms |
|
Cisplatin |
9.84 | 15577323 |
MESH:D014625 |
Vaginal Neoplasms |
|
Zidovudine |
9.84 | 12579204 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.16 | 15869587 14671159 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
3.81 | 17334414 17678736 16364871 17638931 |
MESH:D014839 |
Vomiting |
|
Cisplatin |
4.29 | 11897121 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.01 | 17120751 |